Abstract:Over the last decade, microglia have been acknowledged to be key players in central nervous system (CNS) under both physiological and pathological conditions. They constantly survey the CNS environment and as immune cells, in pathological contexts, they provide the first host defense and orchestrate the immune response. It is well recognized that under pathological conditions microglia have both sequential and simultaneous, beneficial and detrimental effects. Cell-specific transcriptomics recently became popular in Neuroscience field allowing concurrent monitoring of the expression of numerous genes in a given cell population. Moreover, by comparing two or more conditions, these approaches permit to unbiasedly identify deregulated genes and pathways. A growing number of studies have thus investigated microglial transcriptome remodeling over the course of neuropathological conditions and highlighted the molecular diversity of microglial response to different diseases. In the present work, we restrict our review to microglia obtained directly from in vivo samples and not cell culture, and to studies using whole-genome strategies. We first critically review the different methods developed to decipher microglia transcriptome. In particular, we compare advantages and drawbacks of flow cytometry and laser microdissection to isolate pure microglia population as well as identification of deregulated microglial genes obtained via RNA sequencing (RNA-Seq) vs. microarrays approaches. Second, we summarize insights obtained from microglia transcriptomes in traumatic brain and spinal cord injuries, pain and more chronic neurological conditions including Amyotrophic lateral sclerosis (ALS), Alzheimer disease (AD) and Multiple sclerosis (MS). Transcriptomic responses of microglia in other non-neurodegenerative CNS disorders such as gliomas and sepsis are also addressed. Third, we present a comparison of the most activated pathways in each neuropathological condition using Gene ontology (GO) classification and highlight the diversity of microglia response to insults focusing on their pro- and anti-inflammatory signatures. Finally, we discuss the potential of the latest technological advances, in particular, single cell RNA-Seq to unravel the individual microglial response diversity in neuropathological contexts.

Interpretation of Neurodegenerative GWAS Risk Alleles in Microglia and their Interplay with Other Cell Types

Genetic insights into immune mechanisms of Alzheimer's and Parkinson's disease

Genetic risk for neurodegenerative conditions is linked to disease-specific microglial pathways

GENOME-WIDE INTEGRATION OF ALZHEIMER’S DISEASE GENETICS AND MYELOID CELL GENOMICS IDENTIFIES NOVEL RISK GENES EXPRESSED IN MICROGLIA

Functional characterization of Alzheimer's disease genetic variants in microglia

Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States

Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration

Microglia in Neurodegenerative Diseases

Integration of Alzheimer’s Disease Genetics and Myeloid Genomics Reveals Novel Disease Risk Mechanisms

Genetic Effects on Human Microglia Transcriptome in Neuropsychiatric Diseases

Integration of Alzheimer's Disease Genetics and Myeloid Cell Genomics Identifies Novel Causal Variants, Regulatory Elements, Genes and Pathways

A microglia clonal inflammatory disorder in Alzheimer's Disease

Integration of Alzheimer’s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes

Variant-to-function mapping of late-onset Alzheimer′s disease GWAS signals in human microglial cell models implicates at the locus

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

Using Stems to Bear Fruit: Deciphering the Role of Alzheimer's Disease Risk Loci in Human-Induced Pluripotent Stem Cell-Derived Microglia

Microglia: roles and genetic risk in Parkinson's disease

Microglia Responses in Acute and Chronic Neurological Diseases: What Microglia-Specific Transcriptomic Studies Taught (and did Not Teach) Us

Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis

Myeloid Cells in Alzheimer's Disease: Culprits, Victims or Innocent Bystanders?

MicroRNAs in microglia: deciphering their role in neurodegenerative diseases